Benzinga | Sep 14, 2021 06:13AM EDT

HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8.5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $20 to $8.5.